Cataracts, a common eye condition characterized by clouding of the lens, often lead to blurred vision and, if left untreated, ...

Imagine living with a condition so debilitating it disrupts daily life, yet being told you don’t qualify for disability benefits. This is ...

A systematic review and meta-analysis of five studies suggested that patients on GLP-1 receptor agonists were more likely to ...

A recent drug discovery could eventually help the visually impaired and those suffering from multiple sclerosis, traumatic stroke, and Alzheimer’s disease regain some of their vision and mental ...

Explore a rare case of systemic mastocytosis in a young adult, highlighting its role in unexplained osteoporosis and the need for early testing.

The Phase IIa study REIMAGINE evaluated the safety and preliminary efficacy of vafidemstat in agitation/aggression in borderline personality ...

Our senior health and wellness writer tried an under-desk bike for two weeks – and it did wonders for their fitness and ...

Roche’s Evrysdi tablet receives US FDA approval for the treatment of spinal muscular atrophy: Basel Friday, February 14, 2025, 13:00 Hrs [IST] Roche, announced that the US Food ...

Using glucocorticoids, rituzimab, or certain immunosuppressants to treat connective tissue diseases is associated with greater risks for severe COVID-19-related outcomes.

Selma Blair opens up to PEOPLE about still keeping a “beginner’s mind” in her multiple sclerosis journey, and why she’s ...

She learned that she would have to try, and "fail," on two other drugs before Medicare would cover the new one.